BCMA/CD3 BsAb in the Treatment of High-risk Smoldering Multiple Myeloma

NCT06745687 · clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Collaborators